FDA Newsletter sign up now
-
Psychiatrist gets warning from FDA: The psychiatrist who treated the Broward foster child who killed himself last year is now in hot water with the FDA. [The Miami Herald]
... dated Feb. 4, regulators at the U.S. Food and Drug Administration said Dr. Sohail Punjwani over-medicated children who ... "adhere to the applicable statutory requirements and FDA regulations governing the conduct of clinical investigations." ...
-
FDA warns psychiatrist who treated foster child who killed self
... dated Feb. 4, regulators at the U.S. Food and Drug Administration said Dr. Sohail Punjwani over-medicated children who ... ``adhere to the applicable statutory requirements and FDA regulations governing the conduct of clinical investigations.'' ...
-
FDA Approves Watson's Trelstar 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
... FDA Approves Watson's Trelstar 22.5 mg, the First ... Watson Pharmaceuticals, Inc., today announced the U.S. Food and Drug Administration (FDA) approval of Trelstar 22.5 mg (triptorelin ...
-
FDA asks for risk plan info on diabetes drug
... Pharmaceuticals Inc. said Monday it received a Food and Drug Administration request for information on manufacturing and a ... studies on the much anticipated drug. The FDA request focuses on product labeling for Bydureon, ...
-
FDA Requesting Risk Plan for Bydureon
... Amylin Pharmaceuticals Inc. said it received a Food and Drug Administration request for information on manufacturing and a ... studies on the much anticipated drug. The FDA request focuses on product labeling for Bydureon, ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Amylin shares up on FDA response for diabetes drug
... Pharmaceuticals jumped 13 percent Monday as the Food and Drug Administration asked for more information on its potential ... version of the twice-daily Byetta injection. The FDA request focuses on product labeling for Bydureon, ...
-
Eisai Gets FDA Approval for Longer Dacogen Dose
... Eisai Gets FDA Approval for Longer Dacogen Dose Drug Discovery ... (AP) - Drugmaker Eisai Inc. said the Food and Drug Administration approved a new, longer dosing regimen of ...
-
News and FDA Updates for Amylin (Nasdaq:AMLN), Eli Lilly (NYSE:LLY), Alkermes (Nasdaq:ALKS)
... News and FDA Updates for Amylin (Nasdaq:AMLN), Eli Lilly (NYSE:LLY), ... and Alkermes, Inc. (Nasdaq:ALKS) announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...
-
BiomedReports: News and FDA Updates for Amylin (Nasdaq:AMLN), Eli Lilly (NYSE:LLY), Alkermes (Nasdaq:ALKS)
... calendar database of Clinical Trials and upcoming FDA approvals & decisions. A complete list of ... and Alkermes, Inc. (Nasdaq:ALKS) announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...
-
Watson Pharmaceuticals Inc awarded FDA approval for generic Cardizem LA
... the receipt of approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application ... tablets for the treatment of hypertension. The FDA approval was secured by the company's subsidiary, ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Watson generic hypertension drug gets FDA approval
... Watson generic hypertension drug gets FDA approval The Associated Press | March 15, ... pressure drug Cardizem LA. Watson said the Food and Drug Administration approved an application for diltiazem hydrochloride extended ...
-
FDA Approves Five-Day Dosing Regimen for Dacogen (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)
... FDA Approves Five-Day Dosing Regimen for Dacogen FDA ... Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen ...
-
News and FDA Updates for PPD (Nasdaq:PPDI), Savient (Nasdaq:SVNT), Shire (NASDAQ:SHPGY)
... News and FDA Updates for PPD (Nasdaq:PPDI), Savient (Nasdaq:SVNT), Shire ... Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA (pegloticase) as a treatment ...
-
Cumberland Farms Corrects FDA Food Safety Concerns
... Cumberland Farms Corrects FDA Food Safety Concerns 's warehouse and commissary ... to the chain in September by the Food and Drug Administration, which was "responded to immediately," Christen Graham, ...
-
BiomedReports: News and FDA Updates for PPD (Nasdaq:PPDI), Savient (Nasdaq:SVNT), Shire (NASDAQ:SHPGY)
... calendar database of Clinical Trials and upcoming FDA approvals & decisions. A complete list of ... Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA (pegloticase) as a treatment ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
Presswire
Press Release Distribution Service
- New Green Laundromat, Opens in Citrus Heights [16 Mar 2010]
- RoundTable Group to Congress: Remember Rural! [16 Mar 2010]
News publications
- World News Report
- US Politics Today
- EU Politics Today
- Healthcare Industry Today
- Music Industry Today
- Agriculture Industry Today
- Energy Industry Today
- IT Industry Today
- Airline Industry Today
- Automotive Industry Today
- Finance Industry Today
© 2005-2010